BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao Z, Zhang Y, Li W, Shi C. Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis. Dermatol Ther. 2018;31. [PMID: 29082587 DOI: 10.1111/dth.12568] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Yao H, Xie YX, Guo JY, Wu HC, Xie R, Shi GQ. Polidocanol sclerotherapy for multiple gastrointestinal hemangiomas: A case report. World J Clin Cases 2021; 9(6): 1483-1489 [PMID: 33644219 DOI: 10.12998/wjcc.v9.i6.1483] [Reference Citation Analysis]
2 Marcoux S, Théorêt Y, Dubois J, Essouri S, Pincivy A, Coulombe J, McCuaig C, Powell J, Soulez G, Kleiber N. Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies? Pediatr Blood Cancer 2021;68:e29364. [PMID: 34596969 DOI: 10.1002/pbc.29364] [Reference Citation Analysis]
3 Aoyama T, Fukumoto A, Shigita K, Asayama N, Mukai S, Nagata S. Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma. Intern Med. 2020;59:1727-1730. [PMID: 32238724 DOI: 10.2169/internalmedicine.4327-19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sun Y, Guo Y, Chen X, Lei S. Effectiveness and Safety of Ethanol for the Treatment of Venous Malformations: A Meta-Analysis. Dermatol Surg 2020;46:1514-8. [DOI: 10.1097/dss.0000000000002389] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu Z, Hu W, Sun J, Wang L, Song D, Guo L. Effectiveness of Polidocanol in the Treatment of Venous Malformations: A Meta-Analysis. Front Pediatr 2022;10:925318. [DOI: 10.3389/fped.2022.925318] [Reference Citation Analysis]
6 Gao Z, Jiao R, Zhang W, Guo W, Li W, Shi C, Liu F, Zhang W, Zhang Y. Retrospective analysis of off-label medication use at a plastic surgery hospital in China and evidence-based evaluation. Dermatol Ther 2021;34:e14424. [PMID: 33070423 DOI: 10.1111/dth.14424] [Reference Citation Analysis]
7 Lin P, Chen F, Chen J, Jiang C. Aesthetic outcome of intralesional injection of lauromacrogol as a single‐agent treatment for uncomplicated infantile hemangiomas: A long‐term follow‐up study. J Dermatol 2020;47:1119-25. [DOI: 10.1111/1346-8138.15473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Chai Y, Zhou Z, Song J, Lv R, Xu G, Bi J, Li X, Li Z, Huo R. Safety of intralesional injection of lauromacrogol combined with triamcinolone for infantile hemangiomas. J Dermatol 2019;46:770-6. [PMID: 31270853 DOI: 10.1111/1346-8138.14992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Nguyen QD, Stender C, Bur D, Silapunt S. Polidocanol: A Review of Off-Label Dermatologic Uses. Dermatol Surg 2022;Publish Ahead of Print. [DOI: 10.1097/dss.0000000000003520] [Reference Citation Analysis]
10 Lin Z, Zhu X, Zhou J. Ultrasound-guided percutaneous sclerotherapy versus surgical resection in the treatment of large hepatic hemangiomas: a retrospective study. BMC Surg 2022;22:130. [PMID: 35392876 DOI: 10.1186/s12893-022-01574-3] [Reference Citation Analysis]